A delegation from Sinopharm Holdings paid a visit to Hongda Group for an inspection and study tour.
Release date:
2024-01-27
On January 26, Yu Yijun, Investment Manager of the Investment Management Department at Sinopharm Holdings Headquarters, and his delegation paid a visit to Jiangxi Hongda Medical Device Group Co., Ltd. for an inspection and exchange. Wang Jianghua, Chairman of Hongda Group, along with the company’s management team, extended a warm welcome, and the two sides engaged in in-depth discussions on corporate investment and business cooperation.

Chairman Wang Jianghua extended a warm welcome to Manager Yu Yijun and his delegation, and outlined Hongda Group’s development journey, business portfolio, and future plans. He emphasized that Hongda Group has consistently prioritized innovation and R&D, continuously enhancing product quality and technological capabilities, and expressed his hope to strengthen cooperation with Sinopharm Holdings to jointly advance the medical device industry.

Manager Yu Yijun highly commended Hongda Group’s innovative achievements in the medical device sector and outlined Sinopharm Holdings’ investment philosophy and business strategy. He noted that Hongda Group boasts robust R&D capabilities and strong brand recognition in the medical device field, aligning closely with Sinopharm Holdings’ core business areas. He expressed his hope that the two parties will leverage their respective strengths to engage in comprehensive cooperation across investment, R&D, and market expansion, jointly fostering a thriving industrial ecosystem in the medical device industry.
→ Related News
0791-85628888
在线咨询